Evolocumab limits adverse cardiovascular outcomes among PCI patients
My patients ask about outcome data with PCSK9 inhibitors, is it worth it? Good to see more.
My patients ask about outcome data with PCSK9 inhibitors, is it worth it? Good to see more.
The actions strengthen patient protections and close coverage gaps, helping millions of Americans gain or keep coverage and access care.
The actions strengthen patient protections and close coverage gaps, helping millions of Americans gain or keep coverage and access care.
Watch ACG’s past “Tune It Up” concerts, a dynamic event dedicated to raising awareness about colorectal cancer. Experience an engaging and educational concert.
Combining drugs and extending treatment – a PFS end point is not sufficient
Affiliations Division of Gastroenterology, Hepatology and Endoscopy, Brigham and Women’s Hospital, Boston, MA, USA Harvard Medical School, Boston, MA, USA Already an online subscriber? P.J.…
Our study demonstrates low quality and potentially biased reporting of oncology news on OncLive and TargetedOnc. Careful safeguards, oversight and reporting of relevant FCOI are…
The best approach to late-night snacking
The NHS Long Term Plan seeks to mainstream digitally-enabled care across all areas of the NHS. Not only will this enable true transformation of…
Updated on March 13, 2024 The California Consumer Privacy Act of 2018 (CCPA) gives consumers more control over the personal information that businesses collect about…
In conclusion, biscuits reformulated to replace sugar using StRebM or Neotame showed no differences in appetite or endocrine responses, acutely or after a two-week exposure,…